Dr. Antonio Mancini Becomes First Physician To Commercially Implant eCoin In Chicago.
We are proud to announce Dr. Antonio Mancini is the first physician in the greater Chicago metro area to commercially implant eCoin, a small device to treat urge urinary incontinence.
The groundbreaking procedure was performed at the Silver Cross Surgery Center in New Lenox, Illinois, along with Mancini’s highly skilled team. Dr. Antonio Mancini is the first physician in all of Chicago, IL to commercially implant the eCoin device to treat patients with urge urinary incontinence. But it is the first in a territory that includes both Milwaukee & NW Indiana, with over 100 urologists & urogynecologists in that geography.
What is Urge Urinary Incontinence?
Overactive Bladder (OAB) symptoms of urgency, frequency, and leakage are very common for both women and men. They may occur more often as people get older, but that doesn’t mean they are a normal part of aging. Urge Incontinence is often described as when the urge to go is so strong, a person can’t make it to the bathroom. An involuntary loss of or leaking of urine following a sudden, strong desire to urinate.
What is eCoin®?
eCoin® is a revolutionary, nickel-sized implant that delivers gentle stimulation to the tibial nerve near the ankle — providing relief from urge urinary incontinence (UUI) without the need for medications, frequent office visits, painful injections, or recharging. This single procedure offers three to six years of relief and is FDA Approved & Clinically Proven.
Learn more about eCoin technology at www.BladderLeakRelief.com
Dr. Mancini is part of the leadership team as the Chief Strategy Officer of Associated Urological Specialists. He is a member of the American Urological Association, American Osteopathic Association, American College of Osteopathic Surgeons, North Central Section of the American Urological Association and Chicago Urological Society. His areas of interest include minimally invasive surgery, laparoscopy, female urology, urologic oncology, urinary stone disease, erectile dysfunction, and men’s health.
Other Groundbreaking Procedures from Associated Urological Specialists
Dr. Mancini is one of many board-certified urologists at Associated Urological Specialists who have the distinction of being the first to perform groundbreaking treatments for urological issues.
Dr. Arpeet Shah and Dr. Daniel Gerber, both urologists at Associated Urological Specialists, recently teamed up to become the first doctors in Chicagoland to implant a Boston Scientific Penile Prosthesis with the new TENACIO pump.
Associated Urological Specialists was the first urology practice in the state of Illinois to offer patients the Optilume® BPH Catheter System for the treatment of Benign Prostatic Hyperplasia (BPH). Dr. Michael Herzog performed the first procedure in July of 2024.
By teaming up with Advocate Aurora System, Associated Urological Specialists were the first to successfully complete the first set of Sonablate HIFU cases for focal treatment of prostate cancer in Chicago and all of Illinois. Dr. Shah initiated the first case and Dr. Rajesh Patel, President of AUS, and Dr. Aaron Berger, Chief Medical Officer & Director of Clinical Research, are now also able to perform this therapy.
Two other Associated Urological Specialists, Dr. Mark Lyon and Dr. James Sylora were the first to do focal therapy for prostate cancer in 2020. At that time, AUS was the first and only private group in the Chicago area to offer this advanced urology technology to their patients.
Associated Urological Specialists (AUS) is a unified group of Urologists and related specialists committed to providing comprehensive urological care to patients and their families around southwest Chicago and northwest Indiana. AUS has placed a tremendous emphasis on bringing together a highly dedicated and skilled set of Board-Certified professionals, equipped with the latest state of the art tools and techniques, to deliver a full range of urological care.